Psychedelic ethics in practice: The case of ketamine-assisted psychotherapy in Norway
Journal of Psychedelic Studies June 10, 2026 Sina Susanna Schüttler, John Nathaniel Parker, Daniel Münster
Psychedelic therapies are moving from the margins of medicine into clinical practice, bringing unresolved ethical questions to the forefront. Among them, ketamine-assisted psychotherapy (KAP) has gained the widest medical acceptance, particularly for treatment-resistant depression (TRD). In August 2025, this development reached a new stage as Norway became the first country to approve...